Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does angiotensin-II protect against strokes?

M J Brown, J Brown

    Lancet (London, England)
    |August 23, 1986
    PubMed
    Summary

    Bendrofluazide unexpectedly reduced stroke risk more than propranolol in mild hypertension treatment. This may be due to opposing effects on the renin-angiotensin system, suggesting caution with angiotensin-converting-enzyme inhibitors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Learning disabilities. Adapt and survive.

    Nursing times·1992
    Same author

    Intracellular regulation of cell adhesion to extracellular matrix components in murine B16 melanoma cells.

    Melanoma research·1992
    Same author

    The effect of chewing gum use on in situ enamel lesion remineralization.

    Journal of dental research·1992
    Same author

    Pick's disease.

    Bailliere's clinical neurology·1992
    Same author

    A prospective cytogenetic study of 36 cases of DiGeorge syndrome.

    American journal of human genetics·1992
    Same author

    Beliefs and behavioral intentions regarding human immunodeficiency virus testing among New York City runaways.

    The Journal of adolescent health : official publication of the Society for Adolescent Medicine·1992

    Area of Science:

    • Cardiovascular Medicine
    • Neurology
    • Pharmacology

    Background:

    • Mild hypertension management is crucial for preventing cerebrovascular events.
    • The renin-angiotensin system plays a key role in blood pressure regulation and vascular health.
    • Different antihypertensive medications have varying effects on the renin-angiotensin system.

    Purpose of the Study:

    • To compare the effectiveness of bendrofluazide and propranolol in reducing stroke in patients with mild hypertension.
    • To explore the potential role of the renin-angiotensin system in mediating the observed differences in stroke reduction.

    Main Methods:

    • Analysis of data from the Medical Research Council trial for mild hypertension.
    • Comparison of stroke incidence between patients treated with bendrofluazide and propranolol.
    • Hypothesizing the influence of drug actions on the renin-angiotensin system.

    Main Results:

    • Bendrofluazide demonstrated a significant and unexpected benefit in stroke reduction compared to propranolol.
    • The observed difference in efficacy is suggested to be related to the drugs' opposing effects on the renin-angiotensin system.

    Conclusions:

    • Bendrofluazide may offer superior protection against stroke in mild hypertension compared to propranolol.
    • The renin-angiotensin system's role in cerebral vessel protection suggests potential limitations for long-term angiotensin-converting-enzyme inhibitor therapy in hypertension.
    • Further research is warranted to elucidate the precise mechanisms and long-term implications.

    Related Experiment Videos